Bristol-Myers Squibb Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$732.20 | $636.99 | 14.38% | 9 | $654.24B |
| NOVO B | Novo Nordisk A/S | Outperform |
12
|
kr878.70 | kr696.07 | 9.25% | 14 | kr3.86T |
| XOM | Exxon Mobil Corp | Outperform |
4
|
$121.05 | $124.27 | 6.15% | 3 | $474.52B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$148.53 | $174.55 | 14.45% | 3 | $356.43B |
| MRK | Merck | Outperform |
2
|
$127.00 | $130.51 | 9.84% | 11 | $318.60B |
| 857 | PetroChina Company | Outperform |
3
|
HK$7.27 | HK$6.10 | -4.68% | 2 | HK$2.07T |
| AZN | AstraZeneca PLC | Outperform |
17
|
£113.52 | £165.99 | 42.55% | 16 | £169.69B |
| NOVN | Novartis | Hold |
10
|
CHF89.12 | CHF105.00 | 20.68% | 9 | CHF181.47B |
| DHR | Danaher | Outperform |
10
|
$250.41 | $260.33 | 7.82% | 4 | $187.44B |
| PFE | Pfizer | Outperform |
2
|
$26.27 | $32.87 | 16.10% | 6 | $147.23B |
| AMGN | Amgen | Outperform |
4
|
$273.01 | $303.65 | 16.20% | 8 | $144.25B |
| MDT | Medtronic | Outperform |
11
|
$80.38 | $92.47 | 18.81% | 21 | $105.54B |
| BP. | BP p.l.c. | Outperform |
9
|
£5.26 | £7.50 | 42.02% | 13 | £84.77B |
| 386 | China Petroleum & Chemical | Outperform |
3
|
HK$4.71 | HK$5.04 | 2.12% | 4 | HK$815.77B |
| GSK | GSK | Outperform |
12
|
£16.36 | £17.30 | 19.19% | 12 | £65.34B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$233.83 | $284.47 | 19.75% | 8 | $67.64B |
| 4519 | Chugai Pharmaceutical | Outperform |
6
|
¥5.15k | ¥4.92k | 19.39% | 0 | ¥8.48T |
| MMM | 3M | Hold |
10
|
$92.02 | $109.39 | 8.67% | 3 | $51.06B |
| BAS | BASF | Outperform |
12
|
51.32€ | 49.50€ | 9.12% | 2 | 45.02€B |
| A | Agilent Technologies | Outperform |
10
|
$137.49 | $138.82 | 10.19% | 10 | $38.90B |
| MRNA | Moderna | Outperform |
16
|
$108.85 | $135.42 | 14.29% | 1 | $38.83B |
| CTVA | Corteva | Outperform |
12
|
$54.77 | $61.72 | 16.85% | 1 | $38.30B |
| BEI | Beiersdorf | Outperform |
17
|
138.60€ | 137.41€ | 7.50% | 3 | 30.80€B |
| COLO B | Coloplast A/S | Hold |
18
|
kr922.00 | kr812.28 | -1.30% | 5 | kr203.65B |
| BAYN | Bayer | Hold |
5
|
26.97€ | 45.15€ | 18.65% | 4 | 25.86€B |
| IOC | Indian Oil Corporation | Hold |
15
|
Rp168.75 | Rp136.48 | -10.52% | 8 | Rp2.30T |
| BAX | Baxter International Inc | Outperform |
17
|
$40.93 | $44.86 | 9.94% | 5 | $20.10B |
| GMAB | Genmab A/S | Outperform |
16
|
kr1.97k | kr2.71k | 30.07% | 14 | kr130.39B |
| ILMN | Illumina | Outperform |
16
|
$122.87 | $159.28 | 22.08% | 9 | $18.70B |
| 4503 | Astellas Pharma | Outperform |
18
|
¥1.47k | ¥2.64k | 41.25% | 0 | ¥2.65T |
| BGNE | BeiGene | Buy |
6
|
$144.12 | $285.19 | 90.81% | 2 | $13.53B |
| 500124 | Dr. Reddy's Laboratories | Hold |
18
|
Rp5.95k | Rp5.67k | 1.66% | 25 | Rp989.58B |
| INCY | Incyte | Outperform |
9
|
$51.74 | $77.05 | 49.21% | 8 | $11.75B |
| AKZA | Akzo Nobel N.V. | Outperform |
18
|
62.38€ | 79.42€ | 24.24% | 16 | 10.63€B |
| 4523 | Eisai | Outperform |
18
|
¥6.09k | ¥9.58k | 37.95% | 0 | ¥1.69T |
| IPN | Ipsen | Outperform |
17
|
112.30€ | 127.95€ | 4.19% | 0 | 8.95€B |
| CRDA | Croda International Plc | Outperform |
18
|
£46.54 | £65.12 | 9.58% | 6 | £6.81B |
| 5019 | Idemitsu Kosan | Outperform |
13
|
¥927.50 | ¥3.79k | -13.75% | 0 | ¥1.16T |
| 1801 | Innovent Biologics | Buy |
6
|
HK$38.15 | HK$50.72 | 33.16% | 6 | HK$53.87B |
| 4528 | Ono Pharmaceutical | Hold |
18
|
¥2.29k | ¥2.76k | 6.78% | 0 | ¥1.05T |
| EXEL | Exelixis | Outperform |
16
|
$23.71 | $26.44 | 13.88% | 5 | $6.21B |
| APLS | Apellis Pharmaceuticals | Outperform |
6
|
$49.93 | $79.81 | 66.63% | 3 | $5.73B |
| FPE3 | Fuchs | Outperform |
18
|
44.02€ | 43.45€ | 11.31% | 10 | 5.28€B |
| CLN | Clariant | Outperform |
18
|
CHF13.09 | CHF16.11 | 14.59% | 6 | CHF4.33B |
| HLUN A | H. Lundbeck A/S | Outperform |
18
|
kr33.00 | kr190.00 | 10.61% | 6 | kr32.62B |
| 9926 | Akeso | Buy |
4
|
HK$47.45 | HK$49.90 | 16.19% | 0 | HK$35.41B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$31.23 | $44.75 | 26.80% | 0 | $4.17B |
| ALKS | Alkermes | Outperform |
10
|
$24.65 | $33.27 | 37.93% | 3 | $4.04B |
| 300003 | Lepu Medical Technology (Beiji... | Buy |
18
|
¥13.81 | ¥25.02 | 44.82% | 3 | ¥24.79B |
| BHC | Bausch Health Companies | Hold |
15
|
$8.56 | $9.50 | 10.98% | 5 | $3.19B |
| IOVA | Iovance Biotherapeutics | Buy |
4
|
$11.71 | $20.42 | 117.76% | 4 | $3.16B |
| 1548 | Genscript Biotech | Buy |
5
|
HK$10.84 | HK$3.96 | -64.58% | 0 | HK$22.17B |
| MOR | MorphoSys | Outperform |
6
|
67.70€ | 28.78€ | 0.44% | 3 | 2.55€B |
| SDF | K+S | Hold |
8
|
13.68€ | 18.21€ | 16.23% | 8 | 2.33€B |
| PFIZER | Pfizer | Outperform |
18
|
Rp4.15k | Rp4.53k | 18.95% | 3 | Rp207.63B |
| ARQT | Arcutis Biotherapeutics | Outperform |
4
|
$8.75 | $12.00 | 100.00% | 4 | $1.00B |
| 4569 | KYORIN Pharmaceutical | Underperform |
16
|
¥1.79k | ¥0.00 | -16.06% | 0 | ¥106.24B |
| ORGO | Organogenesis Holdings | Outperform |
10
|
$2.98 | $4.75 | 67.79% | 1 | $468.79M |
| 524735 | Hikal | Buy |
18
|
Rp311.75 | Rp328.00 | 5.85% | 1 | Rp36.83B |
| MXCT | MaxCyte | Buy |
8
|
£3.05 | £9.66 | 215.74% | 6 | £344.51M |
| AMRN | Amarin | Hold |
8
|
$0.88 | $2.05 | 13.64% | 1 | $352.89M |
| OMER | Omeros | Hold |
11
|
$3.04 | $13.00 | -100.00% | 2 | $282.89M |
| BLUE | bluebird bio | Hold |
6
|
$0.92 | $7.20 | 334.78% | 2 | $267.91M |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.02 | $10.86 | 296.04% | 3 | $266.16M |
| CDXS | Codexis | Buy |
6
|
$2.80 | $5.83 | 78.57% | 3 | $198.96M |
| IMP | Imexpharm | Outperform |
17
|
₫65.40k | ₫79.05k | 16.21% | 0 | ₫4.85T |
| KPTI | Karyopharm Therapeutics | Outperform |
6
|
$1.09 | $6.00 | 358.72% | 1 | $134.63M |
| DXB | Dimerix |
0
|
$0.34 | $0.00 | 70.59% | 0 | $159.38M | |
| BLRX | BioLineRx | - |
7
|
₪0.17 | ₪1.39 | -100.00% | 0 | ₪302.07M |
| IFRX | InflaRx N.V. | Outperform |
4
|
$1.36 | $9.44 | 408.82% | 2 | $79.49M |
| DMC | Domesco Medical Import - Expor... | - |
0
|
₫56.20k | ₫0.00 | -100.00% | 0 | ₫1.74T |
| MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.18 | $0.65 | 455.56% | 0 | $56.27M |
| ONCO | Oncopeptides AB (publ) |
0
|
kr3.22 | kr6.90 | 98.76% | 0 | kr352.58M | |
| ACST | Acasti Pharma | Buy |
0
|
$2.90 | $16.34 | 177.93% | 0 | $26.98M |
| LSTA | Lisata Therapeutics | Buy |
8
|
$2.83 | $16.00 | 412.37% | 2 | $23.85M |
| TCRT | Alaunos Therapeutics | Hold |
7
|
$1.18 | $1.37 | -100.00% | 3 | $17.93M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
| MPH | Medicure | - |
0
|
C$1.29 | C$2.80 | -100.00% | 0 | C$15.13M |
| GTG | Genetic Technologies |
0
|
$0.12 | $1.00 | -100.00% | 0 | $16.16M | |
| 542934 | Chandra Bhagat Pharma | - |
0
|
Rp111.75 | Rp0.00 | -100.00% | 0 | Rp866.55M |
| APDN | Applied DNA Sciences | Outperform |
10
|
$4.78 | $2.50 | 841.42% | 0 | $10.29M |
| BRTX | BioRestorative Therapies | Outperform |
0
|
$1.27 | $15.00 | 726.77% | 0 | $9.27M |
| AKTX | Akari Therapeutics, Plc | - |
2
|
$1.19 | $80.00 | -100.00% | 0 | $9.24M |
| EMMA | Emmaus Life Sciences | - |
0
|
$0.13 | $4.50 | -100.00% | 0 | $5.90M |
| IPCI | Intellipharmaceutics Internati... | - |
0
|
C$0.08 | C$30.00 | -100.00% | 0 | C$2.65M |
| ATHX | Athersys | - |
6
|
$0.00 | $5.50 | 0.00% | 1 | $0.87M |
| GSAC | GelStat | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.63M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |